Source: Υπουργείο Υγείας (CY) Revision Year: 2015 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Candiplas 2% w/w cream.
Pharmaceutical Form |
---|
Cream. White, soft, homogeneous, smooth, odourless cream for topical application. |
Each 15g and 30g tube of cream contains miconazole nitrate 2% w/w.
Excipients with known effect: chlorocresol and cetostearyl alcohol (quantity).
Each 1g of Candiplas contains 1mg chlorocresol and 77mg cetostearyl alcohol.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Miconazole |
Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis. |
List of Excipients |
---|
Candiplas also contains: Purified water |
Lacquered pilfer proof collapsible aluminium tubes, crimped at bottom and sealed with a polypropylene screw cap containing 15g or 30g of cream, in a carton with a patient information leaflet.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19935
Date of first authorisation: 13/03/1990
Date of renewal authorization: 14/09/2011
Drug | Countries | |
---|---|---|
CANDIPLAS | Cyprus, Hong Kong, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.